HOME > Program > Program Detail

Keynote Speech (그랜드볼룸 104+105호)

  • 10:30 ~ 11:00

    Speaker 1

    진대제한국블록체인협회 회장

    Industry 4.0 and Blockchain

  • 11:00 ~ 11:30

    Speaker 2

    Lotta LjungqvistPresident & CEO, GE Nordics

    Technology Trends in Bioprocessing

  • 11:30 ~ 12:00

    Speaker 3

    Muthiah ManoharanSenior Vice President, Alnylam Pharmaceuticals

    RNA Interference (RNAi) Based Therapeutics: From Principles to Patients

Session 1 (그랜드볼룸 104호)

AI & New Drug

AI and the Future of Healthcare
Chair_김남국_서울아산병원 교수
  • 13:30 ~ 13:45

    Chair

    김남국서울아산병원 교수

    Introductory Speech

  • 13:45 ~ 14:05

    Speaker 1

    Megan HeSenior Director, IQVIA
    Hui JinAssociate Director, IQVIA

    Advanced Analytics and Machine Learning in Healthcare

  • 14:05 ~ 14:30

    Speaker 2

    Maya R.SaidCEO, Outcomes4Me

    AI Innovation for New Drug Development

  • 14:30 ~ 14:50

    Speaker 3

    강상구메디사피엔스 대표이사

    AI trends in bio industry. What should bio industry adapt from IT and AI arena

  • 14:50 ~ 15:10

    Speaker 4

    김태순신테카바이오 사장

    AI Drug Development in the Era of Precision Medicine.

  • 15:10 ~ 15:35

    Speaker 5

    Andrew RadinCo-Founder,twoXAR

    Partnering in AI-Driven Drug Development

  • 15:35 ~ 16:00

    Q&A

Session 2 (그랜드볼룸 105호)

Cell & Gene Therapy

Recent Highlights of Advanced Therapy: Making Dead Cells Work
Chair_이병건_SCM생명과학 대표이사
  • 13:30 ~ 13:35

    Chair

    이병건SCM생명과학 대표이사

    Introductory Speech

  • 13:35 ~ 13:50

    Speaker 1

    Patrick Y. LuFounder, President & CEO, Sirnaomics

    Novel siRNA Therapeutics for Immune Oncology Application with Polypeptide Nanoparticle Delivery Technology

  • 13:50 ~ 14:05

    Speaker 2

    정경은에스티팜 연구본부장

    Outlook for Development of Oligonucleotide Therapeutics and Readiness for Commercial Manufacturing.

  • 14:05 ~ 14:20

    Speaker 3

    이동기올릭스 대표이사

    Asymmetric siRNA Targeting Fibrotic and Ocular Disorders

  • 14:20 ~ 14:35

    Speaker 4

    박한오바이오니아 대표이사

    RNAi Nano-drug & SAMiRNA™

  • 14:35 ~ 14:50

    Speaker 5

    나한익바이로메드 총괄실장

    ViroMed and its lead product VM202: Plasmid DNA Gene Therapy Technology and its target indications

  • 14:50 ~ 15:05

    Speaker 6

    안병옥SL VAXiGEN 대표이사

    Innovative Gene- and DC-based Vaccine against Cancer and Chronic Infection

  • 15:05 ~ 15:20

    Speaker 7

    김수정코오롱생명과학 연구소장

    Kolon Life Science: a leading gene therapy pipeline

  • 15:20 ~ 15:35

    Speaker 8

    서광원강스템바이오텍 연구소장

    Stem cell therapeutics in Atopic dermatitis

  • 15:35 ~ 15:50

    Speaker 9

    이승진메디포스트 본부장

    Commercialization of Advanced Allogeneic Cell Therapy Product in Korea and beyond.

  • 15:50 ~ 16:05

    Speaker 10

    송순욱SCM생명과학 부사장

    Clonal Mesenchymal Stem Cell Products for the Treatment of Immune Diseases

Session 3 (그랜드볼룸 101호)

Biobased Chemical (공동주관 KIST-Europe)

Biobased Chemical Industry: The Green Convergence of Industrial Biotechnology and Chemistry Chair
Chair_서진호_서울대학교 교수
  • 13:30 ~ 13:30

    Chair

    서진호서울대학교 교수

    Introductory Speech

  • 13:30 ~ 13:55

    Speaker 1

    Jens TorslovHead of Projects, Danisch Hydraulic Institute

    EU regulation of medical devices and in-vitro diagnositcs and borderlines to EU REACH

  • 13:55 ~ 14:20

    Speaker 2

    전현표KIST-Europe 팀장

    Main issues of EU REACH regulation and compliance strategies

  • 14:20 ~ 14:45

    Speaker 3

    나진성한국생산기술연구원 수석연구원

    Korean company’s compliance with Act on the Registration and Evaluation of Chemicals and improvements

  • 14:45 ~ 15:10

    Speaker 4

    R. PuvaneswariCEO, MYBiomass

    Biorefinary in Malaysia

  • 15:10 ~ 15:35

    Speaker 5

    조광명CJ제일제당 상무

    Global Trends in Bio-based Materials and Critical Factors for Successful Market Penetration

  • 15:35 ~ 16:00

    Speaker 6

    진인주인하공업전문대학 총장

    Opportunities and Challenges of Biochemical Industry

Session 4 (그랜드볼룸 104호)

Microbiome

Microbiome: A New World of Bio-Healthcare Innovations
Chair_이동호_분당서울대병원 교수
  • 16:30

    Chair

    이동호분당서울대병원 교수

    Introductory Speech

  • 16:30 ~ 16:45

    Speaker 1

    박한수지놈앤컴퍼니 연구소장

    Microbiome and Precision Medicine

  • 16:45 ~ 17:00

    Speaker 2

    남태욱고바이오랩 연구소장

    Exploit the Microbiome to Treat Diseases

  • 17:00 ~ 17:15

    Speaker 3

    장명호지아이이노베이션 최고전략책임자

    Microbiome with new biologics regulate allergic diseases

  • 17:15 ~ 17:30

    Speaker 4

    김병용천랩 연구소장

    Towards standards for microbiome analysis in human gut study

  • 17:30 ~ 17:45

    Speaker 5

    이정일제이영헬스케어 대표이사

    Influence of PLANT POWERED MEATS on the human microbiome

  • 17:45 ~ 18:00

    Q&A

Session 5 (그랜드볼룸 101호)

Gene Editing

Gene Editing: Therapeutic revolution or Biotechnology Innovation?
Chair_이은주_서울대병원 교수
  • 16:30 ~ 16:35

    Chair

    이은주서울대병원 교수

    Introductory Speech

  • 16:35 ~ 16:50

    Speaker 1

    윤경애법무법인 율촌 변리사

    CRISPR/Cas9 Gene Editing Technology: Current Status and Future Prospects

  • 16:50 ~ 17:05

    Speaker 2

    이정민툴젠 연구소장

    CRISPR/Cas9-mediated generation of next generation CAR-T

  • 17:05 ~ 17:20

    Speaker 3

    김홍석마크로젠 부문장

    CRISPR system for Precise gene editing in vivo

  • 17:20 ~ 17:35

    Speaker 4

    조선영아벨리노 R&D본부장

    Gene therapy for Corneal Dystrophy

  • 17:35 ~ 17:50

    Speaker 5

    강정택엠젠플러스 연구소장

    Advanced research for generation of genetically engineered pigs using gene editing technology

  • 17:50 ~ 18:00

    Q&A

Session 6 (그랜드볼룸 105호)

Brain

Recent Breakthrough in Brain Disorders
Chair_배애님_치매DTC융합연구단 단장
  • 16:30 ~ 16:30

    Chair

    배애님치매DTC융합연구단 단장

    Introductory Speech

  • 16:30 ~ 16:50

    Speaker 1

    배애님치매DTC융합연구단 단장

    Tau-targeted therapeutic strategy for the treatments of Alzheimer’s disease

  • 16:50 ~ 17:05

    Speaker 2

    정진석동아ST 수석연구원

    Development of anti-Parkinson’s disease drug in USA

  • 17:05 ~ 17:20

    Speaker 3

    이기원와이브레인 대표이사

    The Stimulated Brain: Recent Trends in Non-invasive Neurostimulation based Therapeutic Medical Devices

  • 17:20 ~ 17:35

    Speaker 4

    김동현뉴로핏 최고기술책임자

    Guiding technology for electrical brain stimulation

  • 17:35 ~ 17:50

    Speaker 5

    최영식한국뇌연구원 부장

    Three dimensional aspects of Alzheimer’s disease

  • 17:50 ~ 18:00

    Q&A